Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Thyroid Cancer, Papillary × Mitoxantrone × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Promyelocytic, Acute 2 Thyroid Cancer, Papillary 1 Neuromyelitis Optica 1 Myelitis, Transverse 1 Leukemia, Myeloid, Acute 1 Demyelinating Autoimmune Diseases, CNS 1 Autoimmune Diseases of the Nervous System 1

Interventions

Thyroid (USP) 1 Mitoxantrone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07354698 2026-01-21

MHI

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 4 Not yet recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡